Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Guerbet S.A.
Industry Sector: HealthTechnology
CEO: David Hale
Number Of Employees: 2,905
Enterprise Value: $705,220,399
PE Ratio: 15.5
Exchange/Ticker 1: Euronext Paris:GBT
Exchange/Ticker 2: N/A
Latest Market Cap: $283,216,319
BioCentury | Dec 19, 2019
Finance
Truffle’s recipe for company creation
Truffle Capital plans to deploy €250M fund to scour the U.S., Europe for IP to build biotechs, medtechs
BioCentury | Sep 25, 2019
Company News
Sept. 24 Company Quick Takes: FDA approves smallpox vaccine; plus Epidyolex, Vitrakvi, Oral semaglutide, Takeda-Evotec, Guerbet-IBM Watson
BioCentury | Jan 12, 2018
Financial News
Truffle Capital raises $102M toward life science and medtech fund
BioCentury | Jan 10, 2018
Financial News
Truffle Capital raises $102M toward life science and medtech fund
Items per page:
1 - 10 of 24